About Sagent Pharmaceuticals
Sagent Pharmaceuticals is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.
Missing: Sagent Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Sagent Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Sagent Pharmaceuticals
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Sagent Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Latest Sagent Pharmaceuticals News
Feb 19, 2022
The newly added Leucovorin Calcium market research report by Value Market Research disclose all the important information associated with the market such as value, growth factor, trends, market share, size, and challenges for the forecasted timeline 2020-2028. The major players in the leucovorin calcium market include Pfizer, Eli Lilly, Hikma Pharmaceuticals, Sagent Pharmaceuticals, Jiangsu Hengrui Medicine. Get more information on "Global Leucovorin Calcium Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Leucovorin Calcium Market Research Report with detailed TOC at https://www. Purchase Complete Global Leucovorin Calcium Market Research Report at https://www.
Sagent Pharmaceuticals Frequently Asked Questions (FAQ)
When was Sagent Pharmaceuticals founded?
Sagent Pharmaceuticals was founded in 2006.
Where is Sagent Pharmaceuticals's headquarters?
Sagent Pharmaceuticals's headquarters is located at 1901 N Roselle Road, Schaumburg.
What is Sagent Pharmaceuticals's latest funding round?
Sagent Pharmaceuticals's latest funding round is Acq - P2P.
How much did Sagent Pharmaceuticals raise?
Sagent Pharmaceuticals raised a total of $70M.
Who are the investors of Sagent Pharmaceuticals?
Investors of Sagent Pharmaceuticals include Nichi-Iko Pharmaceutical, Zhejiang Hisun Pharmaceutical, Vivo Capital, Biotechnology Development Fund and Kaiwu Capital.
Who are Sagent Pharmaceuticals's competitors?
Competitors of Sagent Pharmaceuticals include Capnia, Transcept Pharmaceuticals, Catalent, Quinnova Pharmaceuticals, Ekos and 11 more.
Compare Sagent Pharmaceuticals to Competitors
Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibility Studies, Prototype Development, Formulation Optimization, Clinical Trials, Regulatory Compliance, Process Scale-up, and Full Scale Manufacturing.
EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.
Kucera Pharmaceutical Company is based in Winston-Salem, NC. The company started with a drug delivery approach that combined or conjugated delivery molecules with therapeutic molecules as a platform technology, both to improve the properties of the attached therapeutic molecules (making them orally available and improving distribution) and to extend patent life.
Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.
MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm drug delivery technology to develop products that improve patient outcomes and address unmet needs. PharmFilm can benefit patients by improving the efficacy, safety, and convenience of pharmaceutical and over-the counter products.
Pharmaceutical company focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.